blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1784201

EP1784201 - PHYSIOLOGICALLY ACTIVE COMPOSITION AGAINST DIABETES [Right-click to bookmark this link]
Former [2007/20]PHYSIOLOGICALLY ACTIVE COMPOSITION
[2010/16]
StatusNo opposition filed within time limit
Status updated on  26.08.2011
Database last updated on 18.05.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
Phytomedics Incorporated
2245 RT. 13, Suite 103
Dyton, NJ 08810 / US
[2010/35]
Former [2007/20]For all designated states
Cargill, Incorporated
15407 McGinty Road West
Wayzata, MN 55391 / US
Inventor(s)01 / JÄGER, Ralf
2138 E. Lafayette Pl.
Milwaukee, WI 53202 / US
02 / WENK, Hans-Henning
Westminsterstr. 47
D-45470 Mülheim a.d. Ruhr / DE
03 / DIECK, Heike, Tom
Thalhauser Strasse 21
D-85354 Freising / DE
04 / HOPPE, Hans, Ullrich
Meisenstr. 14
85416 Lagenbach / DE
05 / RABELER, Roland
Ludwig Thomastr. 2A
85356 Freising / DE
 [2008/12]
Former [2007/47]01 / JÄGER, Ralf
2138 E. Lafayette Pl.
Milwaukee, WI 53202 / US
02 / WENK, Hans-Henning
Moltkeplatz 43
45138 Essen / DE
03 / DIECK, Heike, Tom
Heinestrasse 11
85354 Freising / DE
04 / HOPPE, Hans, Ullrich
Meisenstr. 14
85416 Lagenbach / DE
05 / RABELER, Roland
Ludwig Thomastr. 2A
85356 Freising / DE
Former [2007/21]01 / JÄGER, Ralf
2138 E. Lafayette Pl.
Milwaukee, WI 53202 / US
02 / WENK, Hans-Henning
Moltkeplatz 43
45138 Essen / DE
03 / DIECK, Heike, Tom
Thalhauser Str. 21
85354 Freising / DE
04 / HOPPE, Hans, Ullrich
Meisenstr. 14
85416 Lagenbach / DE
05 / RABELER, Roland
Ludwig Thomastr. 2A
85356 Freising / DE
Former [2007/20]01 / JÄGER, Ralf
Erdinger Str. 31b
85356 Freising / DE
02 / WENK, Hans-Henning
Jagdstr. 13
85356 Freising / DE
03 / DIECK, Heike, Tom
Thalhauser Str. 21
85354 Freising / DE
04 / HOPPE, Hans, Ullrich
Meisenstr. 14
85416 Lagenbach / DE
05 / RABELER, Roland
Blutenburgstr. 19
80636 München / DE
Representative(s)Böhm, Brigitte, et al
Weickmann & Weickmann
Patent- und Rechtsanwälte PartmbB
Postfach 860 820
81635 München / DE
[N/P]
Former [2007/20]Böhm, Brigitte, et al
Weickmann & Weickmann Patentanwälte Postfach 860 820
81635 München / DE
Application number, filing date05776027.421.07.2005
[2007/20]
WO2005EP07964
Priority number, dateDE2004103604724.07.2004         Original published format: DE102004036047
[2007/20]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO2006010560
Date:02.02.2006
Language:DE
[2006/05]
Type: A2 Application without search report 
No.:EP1784201
Date:16.05.2007
Language:DE
The application published by WIPO in one of the EPO official languages on 02.02.2006 takes the place of the publication of the European patent application.
[2007/20]
Type: B1 Patent specification 
No.:EP1784201
Date:20.10.2010
Language:DE
[2010/42]
Search report(s)International search report - published on:EP01.06.2006
ClassificationIPC:A61K36/282, A61K31/352, A61K31/121, A61P5/48, A61K31/09, A61P3/10, A61K45/06
[2010/16]
CPC:
A61K36/282 (EP,KR,US); A61K31/352 (KR); A23L13/72 (EP);
A23L33/105 (EP,US); A61K31/121 (EP,KR,US); A61K36/33 (US);
A61P3/00 (EP); A61P3/10 (EP); A61P5/00 (EP);
A61P5/48 (EP) (-)
Former IPC [2007/20]A61K36/282, A61K31/352, A61K31/121, A61P5/48, A61K31/09
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/20]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:PHYSIOLOGISCH AKTIVE ZUSAMMENSETZUNG GEGEN DIABETES[2010/16]
English:PHYSIOLOGICALLY ACTIVE COMPOSITION AGAINST DIABETES[2010/16]
French:COMPOSITION PHYSIOLOGIQUEMENT ACTIVE CONTRE LE DIABETE[2010/16]
Former [2007/20]PHYSIOLOGISCH AKTIVE ZUSAMMENSETZUNG
Former [2007/20]PHYSIOLOGICALLY ACTIVE COMPOSITION
Former [2007/20]COMPOSITION PHYSIOLOGIQUEMENT ACTIVE
Entry into regional phase29.01.2007National basic fee paid 
29.01.2007Designation fee(s) paid 
29.01.2007Examination fee paid 
Examination procedure16.06.2006Request for preliminary examination filed
International Preliminary Examining Authority: EP
29.01.2007Examination requested  [2007/20]
25.05.2007Despatch of a communication from the examining division (Time limit: M06)
30.11.2007Reply to a communication from the examining division
23.02.2009Despatch of a communication from the examining division (Time limit: M04)
24.06.2009Reply to a communication from the examining division
01.04.2010Communication of intention to grant the patent
05.08.2010Fee for grant paid
05.08.2010Fee for publishing/printing paid
Opposition(s)21.07.2011No opposition filed within time limit [2011/39]
Fees paidRenewal fee
31.07.2007Renewal fee patent year 03
30.09.2008Renewal fee patent year 04
23.07.2009Renewal fee patent year 05
14.07.2010Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.07.200804   M06   Fee paid on   30.09.2008
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY20.10.2010
CZ20.10.2010
DK20.10.2010
EE20.10.2010
FI20.10.2010
HU20.10.2010
IE20.10.2010
LT20.10.2010
LV20.10.2010
NL20.10.2010
PL20.10.2010
RO20.10.2010
SE20.10.2010
SI20.10.2010
SK20.10.2010
TR20.10.2010
BG20.01.2011
GR21.01.2011
ES31.01.2011
IS20.02.2011
PT21.02.2011
[2013/45]
Former [2013/44]CY20.10.2010
CZ20.10.2010
DK20.10.2010
EE20.10.2010
FI20.10.2010
IE20.10.2010
LT20.10.2010
LV20.10.2010
NL20.10.2010
PL20.10.2010
RO20.10.2010
SE20.10.2010
SI20.10.2010
SK20.10.2010
TR20.10.2010
BG20.01.2011
GR21.01.2011
ES31.01.2011
IS20.02.2011
PT21.02.2011
Former [2013/26]CY20.10.2010
CZ20.10.2010
DK20.10.2010
EE20.10.2010
FI20.10.2010
IE20.10.2010
LT20.10.2010
LV20.10.2010
NL20.10.2010
PL20.10.2010
RO20.10.2010
SE20.10.2010
SI20.10.2010
SK20.10.2010
BG20.01.2011
GR21.01.2011
ES31.01.2011
IS20.02.2011
PT21.02.2011
Former [2011/38]CZ20.10.2010
DK20.10.2010
EE20.10.2010
FI20.10.2010
IE20.10.2010
LT20.10.2010
LV20.10.2010
NL20.10.2010
PL20.10.2010
RO20.10.2010
SE20.10.2010
SI20.10.2010
SK20.10.2010
BG20.01.2011
GR21.01.2011
ES31.01.2011
IS20.02.2011
PT21.02.2011
Former [2011/36]CZ20.10.2010
DK20.10.2010
EE20.10.2010
FI20.10.2010
IE20.10.2010
LT20.10.2010
LV20.10.2010
NL20.10.2010
PL20.10.2010
SE20.10.2010
SI20.10.2010
SK20.10.2010
BG20.01.2011
GR21.01.2011
ES31.01.2011
IS20.02.2011
PT21.02.2011
Former [2011/35]CZ20.10.2010
EE20.10.2010
FI20.10.2010
IE20.10.2010
LT20.10.2010
LV20.10.2010
NL20.10.2010
SE20.10.2010
SI20.10.2010
BG20.01.2011
GR21.01.2011
ES31.01.2011
IS20.02.2011
PT21.02.2011
Former [2011/32]FI20.10.2010
LT20.10.2010
LV20.10.2010
NL20.10.2010
SE20.10.2010
SI20.10.2010
BG20.01.2011
GR21.01.2011
ES31.01.2011
IS20.02.2011
PT21.02.2011
Former [2011/29]FI20.10.2010
LT20.10.2010
LV20.10.2010
NL20.10.2010
SE20.10.2010
SI20.10.2010
BG20.01.2011
GR21.01.2011
IS20.02.2011
PT21.02.2011
Former [2011/23]FI20.10.2010
LT20.10.2010
LV20.10.2010
IS20.02.2011
Former [2011/19]LT20.10.2010
Cited inInternational search[X]EP0183436  (INT FLAVORS & FRAGRANCES INC [US], et al) [X] 1,13,22 * claims 1,2,22,23 *;
 [X]WO9938479  (EDWARDS BOBBY GENE [US]) [X] 1,5-8,13,17,18,22 * claims 5-7,38-50 *;
 [X]WO03020026  (UNIV RUTGERS [US], et al) [X] 1-23 * claims 1-10 * * claim 20 * * page 6, line 35 - page 7, line 36 *;
 [PX]  - MADUREIRA ET AL, "A new sesquiterpene-coumarin ether and a new abietane diterpene and their effects as inhibitors of P-glycoprotein", PLANTA MEDICA, (200412), vol. 26, no. 6, XP018001499 [PX] 1-8,13,22 * the whole document *
 [X]  - MARES D ET AL, "ANTIDERMATOPHYTIC ACTIVITY OF HERNIARIN IN PREPARATION OF CHAMOMILLA RECUTITA (L.) RAUSCHERT", PLANTES MEDICINALES ET PHYTOTHERAPIE, ANGERS, FR, (1993), vol. 26, ISSN 0032-0994, pages 91 - 100, XP000917217 [X] 1-8,13,17,22 * page 99, paragraph 3 * * page 91, paragraph 1 *
 [X]  - JAYASINGHE L ET AL, "Antifungal constituents of the stem bark of Bridelia retusa", PHYTOCHEMISTRY, PERGAMON PRESS, GB, (200302), vol. 62, no. 4, ISSN 0031-9422, pages 637 - 641, XP004404091 [X] 1-8,13,17,22 * page 641, paragraph 3.3.6 *

DOI:   http://dx.doi.org/10.1016/S0031-9422(02)00623-4
 [X]  - MALLAVARAPU G R ET AL, "COMPOSITION OF THE ESSENTIAL OIL OF CYMBOPOGON-TRAVANCORENSIS", PLANTA MEDICA, (1992), vol. 58, no. 2, ISSN 0032-0943, pages 219 - 220, XP008061012 [X] 1-8,13 * table 1 *
 [X]  - XIAO Y-Q ET AL, "STUDIES ON THE CHEMICAL CONSTITUENTS OF ARTEMISIA-ANOMALA", ACTA BOTANICA SINICA, (1986), vol. 28, no. 3, ISSN 0577-7496, pages 307 - 310, XP008061015 [X] 1-9,13,22,23 * abstract *
 [X]  - KOMIYA T ET AL, "STUDIES ON INCHINKO PART 2 STUDIES ON THE COMPOUNDS RELATED TO CAPILLARISIN AND FLAVONOIDS", YAKUGAKU ZASSHI, (1976), vol. 96, no. 7, ISSN 0031-6903, pages 855 - 862, XP008061013 [X] 1-9,13,22,23 * abstract * * page 85 *
 [A]  - OKADA Y ET AL, "Search for naturally occuring substances to prevent the complications of diabetes. II. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, JP, (199508), vol. 43, no. 8, ISSN 0009-2363, pages 1385 - 1387, XP002958799
 [A]  - FONSECA F N ET AL, "Critical assessment of electrolyte systems for the capillary electrophoresis analysis of phenolic compounds in herbal extracts", JOURNAL OF MICROCOLUMN SEPARATIONS, PROVO, UT, US, (2001), vol. 13, no. 6, pages 227 - 235, XP002961061

DOI:   http://dx.doi.org/10.1002/mcs.1047
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.